Submitted:
02 May 2024
Posted:
03 May 2024
You are already at the latest version
Abstract
Keywords:
1. Introduction
2. Materials and Methods
Statistical Analysis
Preoperative Procedures
5-ALA Administration
Exoscopic 5-ALA Guided Surgery Method
3. Results
4. Discussion
5. Conclusions
Funding
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Sanai, N. and M.S. Berger, Surgical oncology for gliomas: the state of the art. Nat Rev Clin Oncol, 2018. 15(2): p. 112-125. [CrossRef]
- Rodriguez-Camacho, A., et al., Glioblastoma Treatment: State-of-the-Art and Future Perspectives. Int J Mol Sci, 2022. 23(13). [CrossRef]
- Lacroix, M., et al., A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg, 2001. 95(2): p. 190-8. [CrossRef]
- Stummer, W., et al., Extent of resection and survival in glioblastoma multiforme: identification of and adjustment for bias. Neurosurgery, 2008. 62(3): p. 564-76; discussion 564-76.
- Altieri, R., et al., Glioma Surgery: Technological Advances to Achieve a Maximal Safe Resection. Surg Technol Int, 2015. 27: p. 297-302.
- Stummer, W., et al., Technical principles for protoporphyrin-IX-fluorescence guided microsurgical resection of malignant glioma tissue. Acta Neurochir (Wien), 1998. 140(10): p. 995-1000. [CrossRef]
- Mansouri, A., et al., The role of 5-aminolevulinic acid in enhancing surgery for high-grade glioma, its current boundaries, and future perspectives: A systematic review. Cancer, 2016. 122(16): p. 2469-78.
- Stummer, W., et al., Randomized, Prospective Double-Blinded Study Comparing 3 Different Doses of 5-Aminolevulinic Acid for Fluorescence-Guided Resections of Malignant Gliomas. Neurosurgery, 2017. 81(2): p. 230-239. [CrossRef]
- Widhalm, G., et al., Strong 5-aminolevulinic acid-induced fluorescence is a novel intraoperative marker for representative tissue samples in stereotactic brain tumor biopsies. Neurosurg Rev, 2012. 35(3): p. 381-91; discussion 391. [CrossRef]
- 10. Montemurro, N., et al., The Exoscope in Neurosurgery: An Overview of the Current Literature of Intraoperative Use in Brain and Spine Surgery. J Clin Med, 2021. 11(1). [CrossRef]
- Fiani, B., et al., The Role of 3D Exoscope Systems in Neurosurgery: An Optical Innovation. Cureus, 2021. 13(6): p. e15878. [CrossRef]
- Roberts, D.W., et al., Adjuncts for maximizing resection: 5-aminolevuinic acid. Clin Neurosurg, 2012. 59: p. 75-8.
- Roessler, K., et al., Intraoperative tissue fluorescence using 5-aminolevolinic acid (5-ALA) is more sensitive than contrast MRI or amino acid positron emission tomography ((18)F-FET PET) in glioblastoma surgery. Neurol Res, 2012. 34(3): p. 314-7. [CrossRef]
- Orillac, C., W. Stummer, and D.A. Orringer, Fluorescence Guidance and Intraoperative Adjuvants to Maximize Extent of Resection. Neurosurgery, 2021. 89(5): p. 727-736. [CrossRef]
- Vogelbaum, M.A., et al., A Prospective Validation Study of the First 3D Digital Exoscope for Visualization of 5-ALA-Induced Fluorescence in High-Grade Gliomas. World Neurosurg, 2021. 149: p. e498-e503. [CrossRef]
- Maeda, M., et al., 5-ALA fluorescence-guided resection of pediatric low-grade glioma using the ORBEYE 3D digital exoscope: a technical report. Childs Nerv Syst, 2023. 39(4): p. 1061-1064. [CrossRef]
- Ikeda, N., et al., The Characteristic of Light Sources and Fluorescence in the 3-Dimensional Digital Exoscope “ORBEYE” for 5-Aminolevulinic Acid-Induced Fluorescence-Guided Surgery Compared with a Conventional Microscope. World Neurosurg, 2022. 167: p. e1268-e1274. [CrossRef]



| Pt | WHO,2021 | Age | Gender | Location | Grade of resection |
|---|---|---|---|---|---|
| 1 | Glioblastoma, 4 | 67 | M | Right frontal | GTR |
| 2 | Glioblastoma, 4 | 80 | F | Right Frontal | GTR |
| 3 | Diffuse glioma,4 | 66 | M | Right Temporal | GTR |
| 4 | Diffuse glioma,4 | 39 | M | Right fronto- parietal | GTR |
| 5 | Glioblastoma, 4 | 42 | M | Right occipital | GTR |
| 6 | Glioblastoma, 4 | 61 | M | Right Insular | STR |
| 7 | Glioblastoma, 4 | 58 | F | Right fronto-temporal | GTR |
| 8 | Glioblastoma, 4 | 64 | M | Left frontal | GTR |
| 9 | Glioblastoma, 4 | 70 | M | Left parietal | GTR |
| 10 | Glioblastoma, 4 | 74 | F | Left frontal | GTR |
| Intensity of fluorescence | Type of tissue |
|---|---|
| Intense red or lava-like | Tumor |
| Faint pink or pinkish | Infliltrating tumor cells |
| Blue | Normal tissue |
|
Fluorecence intensity OE (IR 4.5-5) |
Brightness of the surgical field OE (IR 4.9-5) |
Detailing of the anatomy with the blue filter on OE (IR 4-5) |
|||
| 1 | 5 | 5 | 4.5 | ||
| 2 | 4.5 | 5 | 5 | ||
| 3 | 4 | 5 | 4.5 | ||
| 4 | 4.5 | 4.5 | 4 | ||
| 5 | 5 | 5 | 4.5 | ||
| 6 | 4 | 4.5 | 5 | ||
| 7 | 5 | 5 | 4 | ||
| 8 | 5 | 5 | 4 | ||
| 9 | 5 | 5 | 5 | ||
| 10 | 5 | 5 | 4.5 | ||
| mean | 4.7 | 4.9 | 4.5 | ||
|
Fluorecence intensity OM (IR 4-4,125) |
Brightness of the surgical field OM (IR 3.5-4) |
Detailing of the anatomy with the blue filter OM (IR 3-3.5) |
|||
| 1 | 4 | 3.5 | 3.5 | ||
| 2 | 4 | 4 | 3 | ||
| 3 | 3 | 4 | 3.5 | ||
| 4 | 4 | 3.5 | 3 | ||
| 5 | 4 | 4 | 3.5 | ||
| 6 | 4 | 3.5 | 3 | ||
| 7 | 4.5 | 4 | 3 | ||
| 8 | 4 | 4.5 | 2.5 | ||
| 9 | 4 | 4 | 3.5 | ||
| 10 | 4.5 | 3.5 | 3.5 | ||
| mean | 4.0 | 3.85 | 3.2 |
| Fluorecence intensity OM |
Brightness of the surgical field OE |
Brightness of the surgical field OM |
Detailing of the anatomy with the blue filter OE |
Detailing of the anatomy with the blue filter OM |
|||
| N | 10 | 10 | 10 | 10 | 10 | ||
| Mean | 4.0000 | 4.9000 | 3.8500 | 4.5000 | 3.2000 | ||
| Median | 4.0000 | 5.0000 | 4.0000 | 4.5000 | 3.2500 | ||
| Std. Deviation | .40825 | .21082 | .33747 | .40825 | .34960 | ||
| Range | 1.50 | .50 | 1.00 | 1.00 | 1.00 | ||
| Minimum | 3.00 | 4.50 | 3.50 | 4.00 | 2.50 | ||
| Maximum | 4.50 | 5.00 | 4.50 | 5.00 | 3.50 | ||
| One-Sided p | Two-Sided p | Lower | Upper | ||||
| Fluorecence intensity OE | 35.250 | <.001 | <.001 | 4.70000 | 4.3984 | 5.0016 | |
| Fluorescence intensity OM | 30.984 | <.001 | <.001 | 4.00000 | 3.7080 | 4.2920 | |
|
Brightness of the surgical field OE |
73.500 | <.001 | <.001 | 4.90000 | 4.7492 | 5.0508 | |
|
Brightness of the surgical field OM |
36.076 | <.001 | <.001 | 3.85000 | 3.6086 | 4.0914 | |
|
Detailing of the anatomy with the blue filter OE |
34.857 | <.001 | <.001 | 4.50000 | 4.2080 | 4.7920 | |
|
Detailing of the anatomy with the blue filter OM |
28.945 | <.001 | <.001 | 3.20000 | 2.9499 | 3.4501 | |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).